Latest Breaking News On - Scius communications - Page 1 : comparemela.com

TILT Biotherapeutics Presents Clinical Data on TILT-123 in Ovarian Cancer at ASCO 2024

TILT Biotherapeutics Presents Clinical Data on TILT-123 in Ovarian Cancer at ASCO 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesEteläuomen läiAkseli hemminkiAino kalervoDaniel goochMerck co incMerck kgaAmerican society of clinical oncologyUs department of defenseUniversity of helsinkiMerck sharp dohmeHealth affairsMerck kgaaEuropean innovation councilDepartment of defenseScius communications

TILT Biotherapeutics Presents Clinical Data on TILT-123 in Combination with KEYTRUDA® (pembrolizumab) for Ovarian Cancer at AACR 2024

Results Reveal Mechanism of Action and Correlative Analyses DataHELSINKI, Finland, April 10, 2024 (GLOBE NEWSWIRE) TILT Biotherapeutics (TILT), a clinical-stage biotechnology company developing cancer immunotherapies presented promising preliminary safety and efficacy data from their ongoing Phase I clinical trial (NCT05271318) in platinum resistant or refractory ovarian cancer patients at the American Association for Cancer Research (AACR) Annual Meeting 2024. TILT-123 in combination with MS

Eteläuomen läiUnited statesAkseli hemminkiAino kalervoDaniel goochUs department of defenseMerck kgaaMerck co incMerck sharp dohmeEuropean innovation councilUniversity of helsinkiAmerican association for cancer researchScius communicationsMerck kgaResults reveal mechanismCorrelative analyses

EnteroBiotix Completes £27m Financing Round to Advance Clinical Trials

EnteroBiotix Completes £27m Financing Round to Advance Clinical Trials
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomGlasgow cityDavid gaffneyDaniel goochJames mcilroyThairm bioAnna dickensKineticos life sciencesImperial college londonScottish national investment bankBank is scotlandScius communicationsPartners for scottish national investment bankScottish national investment bank theBiotix completes

TILT Biotherapeutics Awarded USD 2M Grant from US Department of Defense for Ovarian Cancer Immunotherapy Research

TILT Biotherapeutics Awarded USD 2M Grant from US Department of Defense for Ovarian Cancer Immunotherapy Research
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesEteläuomen läiAino kalervoAkseli hemminkiDaniel goochMerck co incOvarian cancer immunotherapy researchEuropean innovation councilUs department of defenseOvarian cancer research program under award noMerck kgaaDepartment of defenseHealth affairsUniversity of helsinkiScius communicationsMerck kga

Anocca Appoints Martin Welschof to Board of Directors

Anocca Appoints Martin Welschof to Board of Directors
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Daniel goochMartin welschofJacob michlewiczReagan jarvisUniversity of bielefeldScius communicationsBioinvent internationalAppoints martin welschofHans str